Skip to content

NYSE · CIK 0001537435

TGEN TECOGEN INC.

Insider trading from SEC Form 4. Last filing 34 d ago. Close $2.42 on Oct 9, 2026, +21% from the 52-week low and -80% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

TGENOct 9, 2026 · close 2.42

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at TECOGEN INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
31WeakStephen Lafaille
VP of Business Development
buy
$1,000
400 shares
-+180% from low-32% from high
50ModerateStephen Lafaille
VP of Business Development
sell
$346k
60,000 shares
-577%+501% from low-2% from high
10WeakEarl R Lewis
director
buy
$1,600
2,000 shares
+0%-
26WeakEarl R Lewis
director
buy
$71k
100,000 shares
+16%-

Transactions

The last 32 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 26, 2026Stephen Lafaille
VP of Business Development
AGrant or award
Common Stock
+29,013$0.00$041,38934 d ago
Jun 26, 2026Robert A Panora
COO and President
AGrant or award
Common Stock
+9,671$0.00$072,19434 d ago
Jun 26, 2026Abinand Rangesh
Chief Executive Officer
AGrant or award
Common Stock
+174,081$0.00$0241,27434 d ago
Jun 26, 2026John Kimball Whiting IV
General Counsel & Secretary
AGrant or award
Common Stock
+19,342$0.00$041,95434 d ago
Jun 26, 2026Roger P. Deschenes
Chief Financial Officer
AGrant or award
Common Stock
+29,013$0.00$081,97534 d ago
Jul 24, 2025John M Albertine
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$8.35$209k175,000Jul 28, 2025
Jul 24, 2025Roger P. Deschenes
CAO
AGrant or award
Common Stock
+17,964$0.00$042,962Jul 28, 2025
Jul 24, 2025Angelina Galiteva
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$8.35$209k225,000Jul 28, 2025
Jul 24, 2025Roger P. Deschenes
CAO
AGrant or award
Stock Option (Right to Buy)derivative
+12,063$8.35$101k152,063Jul 28, 2025
Mar 3, 2025Stephen Lafaille
VP of Business Development
POpen-market purchase
Common Stock
+400$2.50$1,000400Jun 24, 2025
Jun 3, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Common Stock
+10,000$0.71$7,10010,400Jun 24, 2025
Jun 3, 2025Stephen Lafaille
VP of Business Development
SOpen-market sale
Common Stock
-10,000$4.88$49k400Jun 24, 2025
Jun 4, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Common Stock
+15,000$0.71$11k15,400Jun 24, 2025
Jun 4, 2025Stephen Lafaille
VP of Business Development
SOpen-market sale
Common Stock
-15,000$5.00$75k400Jun 24, 2025
Jun 6, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Common Stock
+25,000$1.10$28k25,400Jun 24, 2025
Jun 6, 2025Stephen Lafaille
VP of Business Development
SOpen-market sale
Common Stock
-25,000$5.98$150k400Jun 24, 2025
Jun 23, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Common Stock
+10,000$1.10$11k10,400Jun 24, 2025
Jun 23, 2025Stephen Lafaille
VP of Business Development
SOpen-market sale
Common Stock
-10,000$7.25$73k400Jun 24, 2025
Jun 3, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Stock Options (Right to Buy)derivative
-10,000$0.71$7,10040,000Jun 24, 2025
Jun 4, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Stock Options (Right to Buy)derivative
-15,000$0.71$11k25,000Jun 24, 2025
Jun 6, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Stock Options (Right to Buy)derivative
-25,000$1.10$28k27,500Jun 24, 2025
Jun 23, 2025Stephen Lafaille
VP of Business Development
XIn-the-money exercise
Stock Options (Right to Buy)derivative
-10,000$1.10$11k17,500Jun 24, 2025
Jun 16, 2025Robert A Panora
COO and President
XIn-the-money exercise
Common Stock
+12,723$0.79$10k82,723Jun 20, 2025
Jun 16, 2025Robert A Panora
COO and President
XIn-the-money exercise
Common Stock
+30,000$0.71$21k112,723Jun 20, 2025
Jun 16, 2025Robert A Panora
COO and President
XIn-the-money exercise
Common Stock
+52,500$1.10$58k165,223Jun 20, 2025
May 27, 2025Robert A Panora
COO and President
XIn-the-money exercise
Stock Option (Right to Buy)derivative
+70,000$0.71$50k130,000Jun 2, 2025
May 6, 2025Earl R Lewis
director
XIn-the-money exercise
Common Stock
+15,000$1.75$26k982,256May 7, 2025
May 6, 2025Earl R Lewis
director
XIn-the-money exercise
Common Stock
+12,500$1.20$15k994,756May 7, 2025
May 6, 2025Earl R Lewis
director
XIn-the-money exercise
Common Stock
+6,250$1.10$6,8751,001,006May 7, 2025
May 1, 2025Earl R Lewis
director
JOther
Common Stock
+240,256$2.14$514k967,256May 5, 2025
Nov 22, 2024Earl R Lewis
director
POpen-market purchase
Common Stock
+100,000$0.71$71k737,000Dec 6, 2024
Oct 9, 2023Earl R Lewis
director
POpen-market purchase
Common Stock
+2,000$0.80$1,600637,000Dec 6, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

TGEN insider trading: TECOGEN INC. | InsiderTell